Pharvaris B.V. (PHVS) PT Raised to $79 at Citizens on Agent Trial Success
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben raised the price target on Pharvaris B.V. (NASDAQ: PHVS) to $79.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
